Cetero execs set for bonuses if buyer is found
Cetero Research executives want bonuses if they manage to find a buyer for the ailing firm according to documents filed as part of the CRO's bankruptcy case.
Archives for April 11, 2012
Keep the kids in mind when conducting clinical trials, say Clinigene
Clinigene has called for more companies to consider paediatric applications of drugs from the beginning of their clinical trials.
Roundup of eClinical news
Outsourcing-Pharma presents a roundup of eClinical news, including an update at Medidata to drive growth in 2012.
Gerresheimer grows sales on syringe & insulin pen demand
Demand for insulin pens and ready-to-fill syringes helped Gerresheimer post double-digit first quarter sales growth and raise its outlook.
Manufacturing expansions round-up
in-PharmaTechnologist brings you a round-up of the latest new facilities and expansions for drugsmakers, including added cytotoxic capabilities for BTL, Jubilant’s launch of a special economic zone in India and plans for a $20m API plant for Omkar.
BASF renames solubilisation and dermatology excipients
BASF has developed a new naming scheme for the solubilisation and dermatology excipients it gained with the acquisition of Cognis.
Lonza and Agennix form tactical alliance
Lonza and Agennix have made a tactical alliance over the Phase III production of a non-small cell lung cancer therapy in the hopes it will improve the chance of joint manufacturing after the commerical launch.